Showing results (71-80 of 99) with videos related to
Sort By:
Pageof 10
Cancer Research|January 1, 1995
Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomasD G Walker, W Duan, E A Popovic, et al.Journal of Neurosurgery|March 1, 1984
Intracranial extension of inflammatory pseudotumor of the orbit. Case reportA H Kaye, J F Hahn, A Craciun, et al.British Journal of Cancer|March 1, 1992
Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapyK W Woodburn, S Stylli, J S Hill, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 25, 2016
The emergent role of exosomes in gliomaJ Gourlay, A P Morokoff, R B Luwor, et al.Neurosurgery|February 1, 1990
Selective uptake of hematoporphyrin derivative into human cerebral gliomaJ S Hill, A H Kaye, W H Sawyer, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 1995
Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizerJ S Hill, S B Kahl, S S Stylli, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1983
The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissuesP C Tagari, A H Kaye, P J Teddy, et al.British Journal of Cancer|September 1, 1994
Evaluation of a morpholinothiolporphyrin for use in photodynamic therapyK W Woodburn, J S Hill, S Stylli, et al.Journal of Neurosurgery|May 1, 1984
CSF smooth-muscle constrictor activity associated with cerebral vasospasm and mortality in SAH patientsA H Kaye, P C Tagari, P J Teddy, et al.Photochemistry and Photobiology|May 1, 1992
Evaluation of porphyrin characteristics required for photodynamic therapyK W Woodburn, N J Vardaxis, J S Hill, et al.Pageof 10